We cannot exclude that longer exposure to HFD may have led to a higher degree of adipose tissue inflammation and hepatic steatosis (Strissel et al, 2007), and, hence, myeloid-specific Fas deletion may have also influenced adipose tissue inflammation and/or hepatic insulin resistance. This evidence concerns the gene FAS and fatty liver disease.